Lucosky Brookman Represents Safety Shot in $16.3 Million Registered Direct Offering and Private Placement
Safety Shot, Inc. (Nasdaq: SHOT), a wellness and dietary supplement company, has closed its previously announced $16.3 million financing, consisting of a registered direct offering and concurrent private placement.
The financing included the sale of 22,993,492 shares of common stock at a purchase price of $0.461 per share in a registered direct offering. In a concurrent private placement, the Company issued warrants to purchase up to 45,986,984 shares of common stock, priced at $0.125 per warrant with an exercise price of $0.461 per share. The warrants are immediately exercisable and will expire five years from the date of issuance.
The capital will be used to strengthen Safety Shot’s balance sheet following shareholder approval of its merger with Yerbaé, support integration efforts, and accelerate commercial growth initiatives.
Lucosky Brookman LLP represented Safety Shot as Company counsel on the registered direct and as Company counsel on the PIPE. Dominari Securities, LLC acted as the exclusive placement agent.
This transaction marks a significant step forward for Safety Shot as it enters its next phase of growth, supported by a strengthened capital position and a strategic partnership with a new institutional investor.